Vaccinex, Inc.
Hedge Funds Holdings
Last updated:
Vaccinex, Inc.‘s stocks are currently a part of 11 hedge funds’ portfolios, which represents 2.93% of the total amount of its stocks outstanding. This makes up a total of 1.24M shares of Vaccinex, Inc.. Compared to the previous quarter, the number fell by -73.46% or -3.44M shares fewer. As for the holding position changes, 27.27% (3) of current hedge fund investors increased the number of shares held, 27.27% (3) of current holders sold a part of the shares held, and 27.27% (3) closed the holdings completely. 3 hedge funds are new holders of Vaccinex, Inc. stock in Q1 2023, it is 27.27% of total holders.
Hedge funds holding Vaccinex (Q3 2018 – Q1 2023)
| Q3 2018 | 13 |
|---|---|
| Q4 2018 | 11 |
| Q1 2019 | 9 |
| Q2 2019 | 10 |
| Q3 2019 | 12 |
| Q4 2019 | 11 |
| Q1 2020 | 12 |
| Q2 2020 | 12 |
| Q3 2020 | 16 |
| Q4 2020 | 18 |
| Q1 2021 | 26 |
| Q2 2021 | 24 |
| Q3 2021 | 21 |
| Q4 2021 | 18 |
| Q1 2022 | 24 |
| Q2 2022 | 25 |
| Q3 2022 | 20 |
| Q4 2022 | 24 |
| Q1 2023 | 11 |
Hedge funds changes in Vaccinex positions (Q3 2018 – Q1 2023)
| Q3 2018 | 13 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2018 | 1 | 3 | 2 | 3 | 2 |
| Q1 2019 | 0 | 4 | 2 | 2 | 1 |
| Q2 2019 | 2 | 2 | 3 | 1 | 2 |
| Q3 2019 | 3 | 3 | 2 | 1 | 3 |
| Q4 2019 | 1 | 3 | 2 | 2 | 3 |
| Q1 2020 | 2 | 2 | 5 | 0 | 3 |
| Q2 2020 | 1 | 3 | 3 | 1 | 4 |
| Q3 2020 | 9 | 5 | 1 | 5 | -4 |
| Q4 2020 | 6 | 5 | 3 | 4 | 0 |
| Q1 2021 | 12 | 8 | 2 | 4 | 0 |
| Q2 2021 | 4 | 6 | 6 | 6 | 2 |
| Q3 2021 | 3 | 5 | 3 | 6 | 4 |
| Q4 2021 | 2 | 4 | 2 | 5 | 5 |
| Q1 2022 | 9 | 6 | 4 | 3 | 2 |
| Q2 2022 | 5 | 8 | 3 | 4 | 5 |
| Q3 2022 | 0 | 8 | 3 | 5 | 4 |
| Q4 2022 | 6 | 3 | 5 | 2 | 8 |
| Q1 2023 | 3 | 3 | 3 | 3 | -1 |
Hedge funds changes in Vaccinex stock options (Q3 2018 – Q1 2023)
| Q3 2018 | 0 | 0 |
|---|---|---|
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 22,000 | 187,000 |
| Q4 2020 | 187,000 | 86,000 |
| Q1 2021 | 617,000 | 845,000 |
| Q2 2021 | 514,000 | 809,000 |
| Q3 2021 | 486,000 | 466,000 |
| Q4 2021 | 136,000 | 100,000 |
| Q1 2022 | 53,000 | 105,000 |
| Q2 2022 | 25,000 | 36,000 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 20,023 | 66 |
| Q1 2023 | 120,000 | 0 |